Mupirocin (Brand Name: Bactroban)
The cream you're asking about is mupirocin 2% (brand name Bactroban), which is used topically for minor MRSA skin infections on areas like the knee. 1, 2
When to Use Mupirocin for MRSA on the Knee
According to IDSA guidelines, mupirocin 2% topical ointment is appropriate for minor skin infections such as impetigo and secondarily infected skin lesions (like eczema, ulcers, or lacerations) caused by MRSA 1. This would include superficial MRSA infections on the knee.
Important Limitations
However, you need to understand that mupirocin is NOT the primary treatment for most MRSA skin infections:
- For abscesses, furuncles, or carbuncles on the knee: The main treatment is incision and drainage, not topical antibiotics 1
- For purulent cellulitis or more extensive infections: Oral antibiotics (clindamycin, TMP-SMX, doxycycline, or linezolid) are required 1
- For complicated or deep infections: IV antibiotics (vancomycin, linezolid, daptomycin) are necessary 1
Critical Caveat: Rising Resistance
Mupirocin resistance is becoming a significant problem globally, which limits its effectiveness:
- Recent data shows 22% prevalence of high-level mupirocin resistance genes (mupA) in MRSA isolates, particularly in ST8 strains 3
- One 2023 study found 22.5% of MRSA strains were mupirocin-resistant 4
- Global meta-analysis shows 13.8% pooled prevalence of mupirocin-resistant MRSA 5
- Previous mupirocin exposure strongly predicts resistance 6
Clinical Implications
Given these resistance patterns, mupirocin should be:
- Reserved for truly minor, superficial MRSA skin infections only
- Not used as monotherapy for anything beyond impetigo-like lesions
- Avoided if the patient has had prior mupirocin exposure
- Considered ineffective in up to 1 in 4 MRSA cases based on current resistance data
Formulation Details
Bactroban cream contains 2.15% mupirocin calcium (equivalent to 2.0% mupirocin free acid) in an oil and water-based emulsion 2. The cream formulation was developed to improve patient compliance and has demonstrated equal or superior efficacy compared to the ointment formulation 7.